Combination Drug Approved for Type 2 Diabetes

| Jan 1, 2003

In October 2002, the U.S. Food and Drug Administration approved an oral type 2 medication that combines glipizide and metformin.

Called Metaglip, the drug was approved for use both as an initial therapy for people whose diabetes cannot be controlled by diet and exercise alone and as a second-line therapy for those whose diabetes cannot be controlled by taking either a sulfonylurea or metformin alone in addition to diet and exercise.

Bristol-Myers Squibb, the drug's manufacturer, says clinical trials showed Metaglip to be more effective in lowering blood-glucose levels than either glipizide or metformin alone.

The company cautions that, in rare cases, Metaglip may cause lactic acidosis (a buildup of lactic acid in the blood), which is a serious—and potentially fatal—condition that occurs mainly in individuals whose kidneys are not functioning properly. Alcohol use also can contribute to lactic acidosis.

Those who should not take Metaglip include people with kidney problems; those who are 80 or older (unless their kidneys have been tested); those who are taking medication for heart failure; and people who are seriously dehydrated, have a serious infection or have had liver disease.

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Food, Government & Policy, Type 2 Issues, Type 2 Medications

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.